跳至主要内容
临床试验/NCT05619133
NCT05619133已完成不适用

Effects and Underlying Mechanisms of Photobiomodulation (PBM) on Health and Well-Being

Seaborough Life Science B.V.1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Shift from baseline in dim light melatonin onset after 5 and after 10 PBM sessions

研究概览

简要总结

The goal of this clinical study is to assess the effects of different photobiomodulation (PBM) conditions in men and women between 25 and 65 years old with daytime sleepiness/drowsiness and /or mild mood complaints but be otherwise healthy. The main question it aims to answer are:

  1. Does PBM significantly affect health and well-being?
  2. Are PBM effects wavelength dependent?
  3. Are PBM effects pulse dependent?
  4. Are the eyes needed to assert an PBM effect or is exposure only to the skin sufficient?
  5. What are the cellular, metabolic pathways underlying the systemic effects of PBM.

Participants will have to:

  1. Exposed themselves 5 times per week during 2 weeks to the PBM stimuli between 9:30 and 12:30.
  2. A week before the baseline measurement, participants will have to start wearing a Fitbit Versa 3, and will have to continuously wear until the end of the study.
  3. In the afternoon of the baseline day as well as in the afternoons after 5 and 10 PBM sessions (week 1 and week 2, respectively), participants will have to go to the lab for blood withdraw.
  4. In the evening of the baseline day as well as in the evenings after 5 and 10 PBM sessions (week 1 and week 2, respectively), participants will have to collect saliva samples as well as to complete questionnaires.

It will be a double-blind placebo-controlled field study with a between subject comparison.

详细描述

Five conditions (groups) will be tested:

Dose (J.cm-2) Wavelength (nm) Pulse (Hz,ms) Duty factor Area Cond 1 6.5 850 15, 8 12% Skin + eyes Cond 2 6.5 940 15, 8 12% Skin + eyes Cond 3 6.5 850 100, 1 12% Skin + eyes Cond 4 0 850 15, 8 12% Skin + eyes Cond 5 6.5 850 15, 8 12% Skin

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy, no chronic disease
  • Age between 25 - 65 years.
  • Suffer from daytime sleepiness/drowsiness and or a mild mood disturbance (ESS >5 or BDI equal to or higher than 13 but lower than 20, PSQI > 5)
  • Participants will have to have a desk type of work and/or have 3 hours per day between 9:30 am and 12:30 at their office/home in which they could sit in front of the lamp.

排除标准

  • Depressive mood (BDI -II > 20)
  • Pregnancy
  • Menopause symptoms
  • Drug use during the last three months known to interfere with sleep, alertness, the biological clock and/or light sensitivity (i.e. regular usage of sleep medication or stimulating substances)
  • Use of immune suppressants. High levels of caffeine intake during a day (5 or more cups, according to https://www.voedingscentrum.nl/encyclopedie/cafeine.aspx#blok7, there are no negative effects expected from 4 caffeine products in normal adults)
  • High alcohol intake (more than 4 for men and more than 3 for women, drinks per day) for more than 5 days in the past month, including binge drinking and heavy drinking according to https://www.niaaa.nih.gov/publications/brochures-and- fact-sheets/alcohol-facts-and-statistics.
  • Participant is not able to refrain from using recreational drugs during the 4 weeks of the study.
  • Shift work schedule in the 3 months prior to participation and/or planned during the 2 weeks of the study
  • Environmental factors in everyday life that may disturb sleep and cannot be prohibited (e.g. young children, noisy environment)
  • Travel over 2 or more time zones in the month prior to participation
  • Travel to sunny holiday locations/wintersports 1 month before participation
  • Personal plans that prevent them for using the intervention during 2 consecutive weeks

研究组 & 干预措施

placebo

No Intervention

No PBM will be emitted from the device; dose: 0 J.cm-2

PBM High standard

Experimental

A PBM high standard dose of 6.5 J.cm-2 with a wavelength of 850 nm, a pulse of 15 Hz and 8 ms and duty factor of 12%

干预措施: PBM (Device)

PBM High wavelength

Experimental

A PBM high dose of 6.5 J.cm-2 with a wavelength of 940 nm, a pulse of 15 Hz and 8 ms and duty factor of 12%

干预措施: PBM (Device)

PBM High pulse

Experimental

A PBM high dose of 6.5 J.cm-2 with a wavelength of 850 nm, a pulse of 100 Hz and 1.2 ms and duty factor of 12%

干预措施: PBM (Device)

PBM High skin only

Experimental

A PBM high standard dose of 6.5 J.cm-2 with a wavelength of 850 nm, a pulse of 15 Hz and 8 ms and duty factor of 12%, but in this case the participants will wear filtering googles which will not allow PBM from entering the eyes

干预措施: PBM (Device)

结局指标

主要结局

Shift from baseline in dim light melatonin onset after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Saliva

Change from baseline in objective sleep quality scores after 5 and after 10 PBM sessions

时间窗: Through study completion

Fitbit Versa 3

Change from baseline in il-1 concentrations after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Blood

Change from baseline in subjective drowsiness after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Epworth Sleepiness Scale, 0-24, higher score means worse

Change from baseline in TGF-beta1concentrations after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Blood

Change from baseline in depressions scale after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Beck Depression Inventory Second Edition, 0-63, higher score means worse

Change from baseline in general activation after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Activation-Deactivation check list, 5-20, higher score means better

Change from baseline in il-6 concentrations after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Blood

Change from baseline in subjective mood after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Mood VAS scale, 0-10, higher score means better

Change from baseline in deactivation after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Activation-Deactivation check list, 11-14, higher score means worse

Change from baseline in subjective sleep quality scores after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Pittsburgh Sleep quality scale, 0-21, higher score means worse

Change from baseline in IFN- gamma concentrations after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Blood

Change from baseline in TNF-alpha concentrations after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Blood

Change from baseline in high activation after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Activation-Deactivation check list, 5-20, higher score means worse

Change from baseline in general deactivation after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Activation-Deactivation check list, 5-20, higher score means worse

Change from baseline in resting heart rate after 5 and after 10 PBM sessions

时间窗: Through study completion

Fitbit Versa 3

Change from baseline in cortisol levels at bedtime after 5 and after 10 PBM sessions

时间窗: Baseline, after 2 weeks, after 4 weeks

Saliva

Change from baseline in targeted metabolomics concentration after 5 and after 10 PBM sessions

时间窗: Baseline, after 4 weeks

Blood

次要结局

未报告次要终点

研究者

发起方
Seaborough Life Science B.V.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验